Inhibition of BAK-mediated apoptosis by the BH3-only protein BNIP5

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• The BCL-2 protein family regulates apoptosis, a crucial cellular process.
• Mitochondrial outer membrane permeabilization (MOMP) is a key step in apoptosis, driven by BAX and BAK.
• The balance between anti-apoptotic (e.g., MCL-1) and pro-apoptotic (e.g., BIM) proteins controls BAX/BAK activation.

Purpose of the Study:

• To identify novel regulators of apoptosis using a genome-wide screen.
• To investigate the role of BNIP5 in the regulation of BAX and BAK.
• To elucidate the mechanism by which BNIP5 affects apoptosis.

Main Methods:

• Genome-wide CRISPR-dCas9 transactivation screen.
• Cell-based assays to assess apoptosis and BAK/BAX activation.
• Analysis of protein-protein interactions and domain function (BH3 domain).

Main Results:

• BNIP5 was identified as an inhibitor of BAK- but not BAX-induced apoptosis.
• BNIP5 blocked BAK activation across various cell types and cytotoxic treatments.
• The BH3 domain of BNIP5 is essential and sufficient for inhibiting BAK activation.
• BNIP5 selectively activates BAK but poorly de-represses BAK-pro-survival protein complexes.
• BNIP5 promotes BAK binding to MCL-1/BCL-xL, inhibiting apoptosis in a BAX-independent manner.

Conclusions:

• BNIP5 functions as a selective BAK activator and can act as an anti-apoptotic BH3-only protein.
• BNIP5's mechanism involves modulating BAK interactions with pro-survival BCL-2 proteins.
• BNIP5 represents a potential target for modulating apoptosis in therapeutic contexts.